Journal article
Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability
Cell death and differentiation, Vol.10(6), pp.740-748
06/2003
DOI: 10.1038/sj.cdd.4401233
PMID: 12761582
Abstract
Bax is a Bcl-2 family member that promotes apoptosis but has paradoxical effects on lymphoma development in p53-deficient mice. To better understand the mechanism of Bax-induced lymphoma development, the effect of Bax levels, p53 status and Bcl-2 coexpression on lymphoma development were determined. In addition, DNA content and cytogenetics were performed on young (premalignant) Lck-Bax mice as measures of genetic instability. Bax promoted lymphoma development in p53-deficient mice in a dose-dependent manner. Bax expression also led to lymphoma development in both p53 +/- and +/+ animals. Ploidy analysis in mice prior to the onset of overt thymic lymphomas demonstrated that Lck-Bax transgenic mice were more likely to be aneuploid and demonstrate increased chromosome instability. With tumor progression, aneuploidy increased and Bax expression was maintained. Importantly, coexpression of Bcl-2 delayed lymphoma development in Lck-Bax transgenic mice. These data support a model in which increased sensitivity to apoptosis leads directly to chromosome instability in developing T cells and may explain a number of paradoxical observations regarding Bcl-2 family members and the regulation of cancer.
Details
- Title: Subtitle
- Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability
- Creators
- J J Luke - Department of Pathology, The University of Iowa Roy J. and Lucille P. Carver College of Medicine, Iowa City 52242, USAC I Van De WeteringC M Knudson
- Resource Type
- Journal article
- Publication Details
- Cell death and differentiation, Vol.10(6), pp.740-748
- Publisher
- England
- DOI
- 10.1038/sj.cdd.4401233
- PMID
- 12761582
- ISSN
- 1350-9047
- eISSN
- 1476-5403
- Language
- English
- Date published
- 06/2003
- Academic Unit
- Pathology; Radiation Oncology
- Record Identifier
- 9984047760702771
Metrics
17 Record Views